Glycemic Control after Total Pancreatectomy for Intraductal Papillary Mucinous Neoplasm: An Exploratory Study

Table 3

Comparison of presence of HbA1c <7% after baseline between total pancreatectomy and type I diabetes mellitus patients.

Time after baseline	TP		Type I DM		TP-Type I DM
	Fraction (%) with HbA1c <7%	95% CI	Fraction (%) with HbA1c <7%	95% CI	Difference in proportions (95% CI)	𝑃 value
6 months	1/10 (10%)	0%–45%	33/100 (33%)	24%–43%	−23% (−36%, 9%)	0.17
12 months	3/9 (33%)	7%–70%	14/68 (21%)	12%–32%	13% (−11%, 45%)	0.42
18 months	1/7 (14%)	0%–58%	16/65 (25%)	15%–37%	−10% (−27%, 28%)	1.00
24 months	2/6 (33%)	4%–78%	16/58 (28%)	17%–41%	6% (−21%, 44%)	1.00

𝑃-values result from Fisher’s exact test. (TP: total pancreatectomy; DM: diabetes mellitus).